相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway
Jia Tang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
Jessica R. Allegretti et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
Pieter de Groot et al.
GUT (2020)
Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
Eleonora Scorletti et al.
GASTROENTEROLOGY (2020)
Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed Rats
Eun-Jung Park et al.
NUTRIENTS (2020)
Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome
Na Young Lee et al.
GUT MICROBES (2020)
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial
Laura Craven et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
LactobacillusStrains Alleviated Hyperlipidemia and Liver Steatosis in Aging Rats via Activation of AMPK
Lee-Ching Lew et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study
Aein Azarang et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials
Hana Koutnikova et al.
BMJ OPEN (2019)
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Judith Aron-Wisnewsky et al.
CURRENT DIABETES REPORTS (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
Brandon J. Perumpail et al.
DISEASES (2019)
Current and future pharmacological therapies for NAFLD/NASH
Yoshio Sumida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial
Nazarii Kobyliak et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2018)
Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
Farnush Bakhshimoghaddam et al.
JOURNAL OF NUTRITION (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Early microbiota, antibiotics and health
Alicja M. Nogacka et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial
Elina Manzhalii et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids
Aafke W. F. Janssen et al.
JOURNAL OF LIPID RESEARCH (2017)
Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents
Fatemeh Famouri et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on nonalcoholic fatty liver in rats
Haiqing Ye et al.
FOOD & FUNCTION (2017)
Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
Da Zhou et al.
SCIENTIFIC REPORTS (2017)
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte et al.
CELL METABOLISM (2017)
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
Fatemeh Mofidi et al.
BRITISH JOURNAL OF NUTRITION (2017)
Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease
Anna Janina Engstler et al.
GUT (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Human Intestinal Microbiome in Health and Disease
Susan V. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease
Peter Starkel et al.
SEMINARS IN LIVER DISEASE (2016)
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
J. Mark Brown et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
Jessica M. Yano et al.
CELL (2015)
Cross-talk between bile acids and intestinal microbiota in host metabolism and health
Yang-fan Nie et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis
A. Alisi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Tannaz Eslamparast et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
Valentina Giorgio et al.
DIGESTIVE AND LIVER DISEASE (2014)
Interactions Between the Intestinal Microbiome and Liver Diseases
Bernd Schnabl et al.
GASTROENTEROLOGY (2014)
Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease
S. Nabavi et al.
JOURNAL OF DAIRY SCIENCE (2014)
Choline Supplementation Protects against Liver Damage by Normalizing Cholesterol Metabolism in Pemt/Ldlr Knockout Mice Fed a High-Fat Diet
Ala Al Rajabi et al.
JOURNAL OF NUTRITION (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al.
HEPATOLOGY (2013)
Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
Barbara D. Pachikian et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Feed Your Tregs More Fiber
Julia Bollrath et al.
SCIENCE (2013)
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Henry J. Haiser et al.
SCIENCE (2013)
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
Vincent Wai-Sun Wong et al.
ANNALS OF HEPATOLOGY (2013)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling
Christoph Reinhardt et al.
NATURE (2012)
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
Trond Ulven
Frontiers in Endocrinology (2012)
Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice
Timea Csak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation
Mariann I. Lassenius et al.
DIABETES CARE (2011)
Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
Melanie D. Spencer et al.
GASTROENTEROLOGY (2011)
Novel Evidence for Chronic Exposure to Endotoxin in Human Nonalcoholic Steatohepatitis
Froukje J. Verdam et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice
Evelyne M. Dewulf et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu et al.
SCIENCE (2011)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Jill A. Parnell et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease
Luca Miele et al.
HEPATOLOGY (2009)
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice:: Role of endotoxin
Ina Bergheim et al.
JOURNAL OF HEPATOLOGY (2008)
The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing
Les Dethlefsen et al.
PLOS BIOLOGY (2008)
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani et al.
DIABETES (2007)
Prebiotics: The concept revisited
Marcel Roberfroid
JOURNAL OF NUTRITION (2007)
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases
C Loguercio et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study
CA Daubioul et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2005)
Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats
CK Hsu et al.
JOURNAL OF NUTRITION (2004)
Effect of alcohol consumption on the gut
C Bode et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2003)
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis
AJ Wigg et al.
GUT (2001)
分享论文
